These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17374756)

  • 1. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
    Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
    Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2006 Apr; 87(Pt 4):861-871. PubMed ID: 16528036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
    Branza-Nichita N; Durantel D; Carrouée-Durantel S; Dwek RA; Zitzmann N
    J Virol; 2001 Apr; 75(8):3527-36. PubMed ID: 11264342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
    Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
    J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis].
    Timokhova AV; Bakinovskiĭ LV; Zinin AI; Popenko VI; Ivanov AV; Rubtsov PM; Kochetkov SN; Belzhelarskaia SN
    Mol Biol (Mosk); 2012; 46(4):644-53. PubMed ID: 23113354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
    Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
    Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins.
    Tani H; Komoda Y; Matsuo E; Suzuki K; Hamamoto I; Yamashita T; Moriishi K; Fujiyama K; Kanto T; Hayashi N; Owsianka A; Patel AH; Whitt MA; Matsuura Y
    J Virol; 2007 Aug; 81(16):8601-12. PubMed ID: 17553880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins.
    Kalemera MD; Capella-Pujol J; Chumbe A; Underwood A; Bull RA; Schinkel J; Sliepen K; Grove J
    J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33147126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
    Whitby K; Taylor D; Patel D; Ahmed P; Tyms AS
    Antivir Chem Chemother; 2004 May; 15(3):141-51. PubMed ID: 15266896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.
    Qu X; Pan X; Weidner J; Yu W; Alonzi D; Xu X; Butters T; Block T; Guo JT; Chang J
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1036-44. PubMed ID: 21173177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.
    Helle F; Wychowski C; Vu-Dac N; Gustafson KR; Voisset C; Dubuisson J
    J Biol Chem; 2006 Sep; 281(35):25177-83. PubMed ID: 16809348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Hoke GM; Sarngadharan MG
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins.
    Sandrin V; Boulanger P; Penin F; Granier C; Cosset FL; Bartosch B
    J Gen Virol; 2005 Dec; 86(Pt 12):3189-3199. PubMed ID: 16298963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.
    Helle F; Vieyres G; Elkrief L; Popescu CI; Wychowski C; Descamps V; Castelain S; Roingeard P; Duverlie G; Dubuisson J
    J Virol; 2010 Nov; 84(22):11905-15. PubMed ID: 20844034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.
    Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R
    Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
    Russell RS; Kawaguchi K; Meunier JC; Takikawa S; Faulk K; Bukh J; Purcell RH; Emerson SU
    J Viral Hepat; 2009 Sep; 16(9):621-32. PubMed ID: 19302336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
    Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
    Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.